NWRN — Newron Pharmaceuticals SpA Share News
0.000.00%
Last trade - 00:00- CH₣174.16m
- CH₣182.76m
- €19.13m
Swiss stocks - Factors to watch on March 5
Brief: Newron Pharmaceuticals FY Net Loss Widens To EUR 20.2 Million
Brief: Newron Starts Clinical Trial With Evenamide In Schizophrenia Patients
Swiss stocks - Factors to watch on December 10
Brief: Newron Pharmaceuticals To Request Type A FDA Meeting
Swiss stocks - Factors to watch on November 26
Brief: Newron Pharmaceuticals SpA Gets Second Tranche From Financing Agreement
Brief: Newron Receives FDA Rare Pediatric Disease Designation For Sarizotan
Brief: Newron Pharmaceuticals Says FDA Grants Rare Pediatric Disease Designation For Sarizotan
Newron shares fall 4.1% as H1 loss doubles on rising costs
Swiss stocks - Factors to watch on September 12
Brief: Newron Pharmaceuticals H1 Net Loss Widens To EUR 14.0 Mln
Swiss stocks - Factors to watch on July 11
Brief: Newron: Zambon And Valeo Pharma Launch Onstryv For Parkinson's disease In Canada
Brief: Newron Pharmaceuticals Reiterates Guidance
Newron: Stock plummets as schizophrenia drug trial delayed
Newron delays schizophrenia drug trial after FDA raises concerns
Brief: Newron Pharmaceuticals Provides Update On Regulatory Status Of Evenamide
Europe Research Roundup: Bawag Group, Fagron, Saga